115 related articles for article (PubMed ID: 16267761)
1. The granzyme B inhibitor SERPINB9 (protease inhibitor 9) circulates in blood and increases on primary cytomegalovirus infection after renal transplantation.
Rowshani AT; Strik MC; Molenaar R; Yong SL; Wolbink AM; Bemelman FJ; Hack CE; Ten Berge IJ
J Infect Dis; 2005 Dec; 192(11):1908-11. PubMed ID: 16267761
[TBL] [Abstract][Full Text] [Related]
2. Expression of granzyme B during primary cytomegalovirus infection after renal transplantation.
Wever PC; Spaeny LH; van der Vliet HJ; Rentenaar RJ; Wolbink AM; Surachno J; Wertheim PM; Schellekens PT; Hack CE; ten Berge IJ
J Infect Dis; 1999 Mar; 179(3):693-6. PubMed ID: 9952379
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional profiles in urine during acute rejection, bacteriuria, CMV infection and stable graft function after renal transplantation.
Øzbay A; Tørring C; Olsen R; Carstens J
Scand J Immunol; 2009 Apr; 69(4):357-65. PubMed ID: 19284501
[TBL] [Abstract][Full Text] [Related]
4. Sero-molecular evaluation of human cytomegalovirus disease in renal transplant rejection.
Kishore J; Mukhopadhyay C; Savitri ; Ayyagari A; Sharma RK
Nepal Med Coll J; 2004 Dec; 6(2):83-7. PubMed ID: 16295735
[TBL] [Abstract][Full Text] [Related]
5. The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection.
Reischig T; Jindra P; Svecová M; Kormunda S; Opatrný K; Treska V
J Clin Virol; 2006 Jun; 36(2):146-51. PubMed ID: 16531113
[TBL] [Abstract][Full Text] [Related]
6. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
[TBL] [Abstract][Full Text] [Related]
7. Severe graft rejection, increased immunosuppression, and active CMV infection in renal transplantation.
von Müller L; Schliep C; Storck M; Hampl W; Schmid T; Abendroth D; Mertens T
J Med Virol; 2006 Mar; 78(3):394-9. PubMed ID: 16419118
[TBL] [Abstract][Full Text] [Related]
8. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of viral load and antigenemia as markers for relapse cytomegalovirus infection in renal transplant recipients].
Franco A; Serrano R; Gimeno A; de Juan J; Merino E; Jiménez del Cerro L; Olivares J
Nefrologia; 2007; 27(2):202-8. PubMed ID: 17564566
[TBL] [Abstract][Full Text] [Related]
10. Urinary cytotoxic molecular markers for a noninvasive diagnosis in acute renal transplant rejection.
Yannaraki M; Rebibou JM; Ducloux D; Saas P; Duperrier A; Felix S; Rifle G; Chalopin JM; Hervé P; Tiberghien P; Ferrand C
Transpl Int; 2006 Sep; 19(9):759-68. PubMed ID: 16918537
[TBL] [Abstract][Full Text] [Related]
11. Control of granzymes by serpins.
Kaiserman D; Bird PI
Cell Death Differ; 2010 Apr; 17(4):586-95. PubMed ID: 19893573
[TBL] [Abstract][Full Text] [Related]
12. Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection.
Kranz B; Vester U; Wingen AM; Nadalin S; Paul A; Broelsch CE; Hoyer PF
Pediatr Transplant; 2008 Jun; 12(4):474-8. PubMed ID: 18466436
[TBL] [Abstract][Full Text] [Related]
13. Hyperexpression of the granzyme B inhibitor PI-9 in human renal allografts: a potential mechanism for stable renal function in patients with subclinical rejection.
Rowshani AT; Florquin S; Bemelman F; Kummer JA; Hack CE; Ten Berge IJ
Kidney Int; 2004 Oct; 66(4):1417-22. PubMed ID: 15458434
[TBL] [Abstract][Full Text] [Related]
14. Molecular signatures of urinary cells distinguish acute rejection of renal allografts from urinary tract infection.
Dadhania D; Muthukumar T; Ding R; Li B; Hartono C; Serur D; Seshan SV; Sharma VK; Kapur S; Suthanthiran M
Transplantation; 2003 May; 75(10):1752-4. PubMed ID: 12777869
[TBL] [Abstract][Full Text] [Related]
15. Clinical correlations of human cytomegalovirus strains and viral load in kidney transplant recipients.
Nogueira E; Ozaki KS; Tomiyama H; Câmara NO; Granato CF
Int Immunopharmacol; 2009 Jan; 9(1):26-31. PubMed ID: 18824137
[TBL] [Abstract][Full Text] [Related]
16. Granzyme expression in fine-needle aspirates from liver allografts is increased during acute rejection.
Kuijf ML; Kwekkeboom J; Kuijpers MA; Willems M; Zondervan PE; Niesters HG; Hop WC; Hack CE; Paavonen T; Höckerstedt K; Tilanus HW; Lautenschlager I; Metselaar HJ
Liver Transpl; 2002 Oct; 8(10):952-6. PubMed ID: 12360440
[TBL] [Abstract][Full Text] [Related]
17. Antibody maturation and viremia after primary cytomegalovirus infection, in immunocompetent patients and kidney-transplant patients.
Steininger C; Kundi M; Kletzmayr J; Aberle SW; Popow-Kraupp T
J Infect Dis; 2004 Dec; 190(11):1908-12. PubMed ID: 15529253
[TBL] [Abstract][Full Text] [Related]
18. Association of the outcome of renal transplantation with antibody response to cytomegalovirus strain-specific glycoprotein H epitopes.
Ishibashi K; Tokumoto T; Tanabe K; Shirakawa H; Hashimoto K; Kushida N; Yanagida T; Inoue N; Yamaguchi O; Toma H; Suzutani T
Clin Infect Dis; 2007 Jul; 45(1):60-7. PubMed ID: 17554702
[TBL] [Abstract][Full Text] [Related]
19. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V
Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451
[TBL] [Abstract][Full Text] [Related]
20. The natural course of cytomegalovirus infection and disease in renal transplant recipients.
Hartmann A; Sagedal S; Hjelmesaeth J
Transplantation; 2006 Jul; 82(2 Suppl):S15-7. PubMed ID: 16858268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
